Antibodies have established themselves as one of the most important classes within the biologics space, and developing these therapeutics requires a series of successful decisions throughout the early-discovery process. Antibody discovery is a complex and often circuitous route, which, if not efficiently optimized, can cost investigators valuable time and money.
In this webinar, our subject matter experts, Christian Olsen and Dr. Nimesh Joseph, provide an overview of current trends in monoclonal antibody research and discovery and how science and technology are converging to create cutting-edge workflows designed to drive innovation and breakthroughs in the largest biologics therapeutic class today.